The United Laboratories International Holdings Limited (ULIHF)

Market Cap	3.80B
Revenue (ttm)	1.89B
Net Income (ttm)	364.39M
Shares Out	n/a
EPS (ttm)	0.20
PE Ratio	10.44
Forward PE	9.45
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29
Average Volume	11
Open	1.750
Previous Close	1.640
Day's Range	1.640 - 1.750
52-Week Range	1.090 - 2.350
Beta	0.12
RSI	20.42
Earnings Date	Aug 29, 2025

About ULIHF

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 17,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: ULIHF

Financial Performance

In 2024, ULIHF's revenue was 13.76 billion, an increase of 0.14% compared to the previous year's 13.74 billion. Earnings were 2.66 billion, a decrease of -1.54%.

Financial numbers in CNY